toceranib-phosphate and Lymphedema

toceranib-phosphate has been researched along with Lymphedema* in 1 studies

Other Studies

1 other study(ies) available for toceranib-phosphate and Lymphedema

Article	Year
Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor. The Canadian veterinary journal = La revue veterinaire canadienne, 2018, Volume: 59, Issue:4 A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphography and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year later. This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosarcoma in a dog. Topics: Animals; Dog Diseases; Dogs; Indoles; Lymphangiosarcoma; Lymphedema; Lymphography; Male; Protein Kinase Inhibitors; Pyrroles; Tomography, X-Ray Computed; Treatment Outcome	2018

Article

Year

Successful management of lymphangiosarcoma in a puppy using a tyrosine kinase inhibitor.

The Canadian veterinary journal = La revue veterinaire canadienne, 2018, Volume: 59, Issue:4

A puppy was diagnosed with lymphangiosarcoma associated with lymphedema based on lymphography and histopathology. The lesions resolved after toceranib therapy, and the dog remains in remission 1 year later. This is the first report of a successful outcome following oral toceranib as first-line therapy for lymphangiosarcoma in a dog.

Topics: Animals; Dog Diseases; Dogs; Indoles; Lymphangiosarcoma; Lymphedema; Lymphography; Male; Protein Kinase Inhibitors; Pyrroles; Tomography, X-Ray Computed; Treatment Outcome

2018